Drugs Made In America Acquisition II Corp. (DMIIU) Accumulated Expenses (2025)

Drugs Made In America Acquisition (DMIIU) has reported Accumulated Expenses for 1 consecutive years, with $88343.0 the latest figure, recorded in Q4 2025.

• In Q4 2025, Accumulated Expenses changed N/A year-over-year to $88343.0; the TTM figure through Dec 2025 stood at $88343.0 (changed N/A YoY), while the FY2025 annual figure was $88343.0, changed N/A from the prior year.
• Accumulated Expenses rose to $88343.0 in Q4 2025 per DMIIU's latest filing, from $5843.0 in the prior quarter.
• Across five years, Accumulated Expenses topped out at $88343.0 in Q4 2025 and bottomed at $5843.0 in Q3 2025.